Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

Showing posts with label LELP. Show all posts
Showing posts with label LELP. Show all posts
24 August 2012

ACS Fall Meeting 2012

›
I recently returned from Philadelphia, where the American Chemical Society held its 244 th national fall meeting. As always this was a ma...
12 March 2012

LLE vs LELP

›
Besides ligand efficiency (LE), a slew of other metrics has been proposed to help evaluate what compounds to take forward in drug discovery....
20 June 2011

Ligand Lipophilicity Efficiency AT Astex Therapeutics

›
Our last post discussed the growing plague of molecular obesity, and how numerous metrics have been designed to control it. In a paper publ...
6 comments:
12 June 2011

Beware molecular obesity

›
Obesity in humans is a growing problem, and not just aesthetically: the condition may be responsible for millions of premature deaths. In a ...
1 comment:
10 April 2009

LELP fragments reach their potential

›
In last month’s issue of Nature Reviews Drug Discovery , György Keserü of Gedeon Richter and Gergely Makara of Merck published a thought-pro...
›
Home
View web version
Powered by Blogger.